DAVITA INC. — Director's Dealing 2016

May 18, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2016-05-13

Reporting Person: HILGER JAMES K (Interim CFO and CAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-13	Common Stock	A	1654	—	Acquired	21130	Direct
2016-05-16	Common Stock	S	3983	$75.5896	Disposed	17147	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-13	Stock Appreciation Rights	$75.42	A	6615	Acquired	2021-05-13	Common Stock (6615)	Direct

Footnotes

F1: The Restricted Stock Units were granted on 5/13/2016. 50% will vest on 5/15/2019 and the remaining 50% will vest on 5/15/2020.

F2: This amount includes 330 shares acquired under Issuer's employee stock purchase plan on 12/31/2015.

F3: Represents the weighted average sale price of $75.5896. The range of prices for the sale of these shares was $75.22 - $75.87, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F4: The Stock Appreciation Rights were granted on 5/13/2016. 50% will vest on 5/13/2019 and the remaining 50% will vest on 5/13/2020.